US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US6056734A
(en)
*
|
1997-02-07 |
2000-05-02 |
Sarcos Lc |
Method for automatic dosing of drugs
|
IN186245B
(pt)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6342250B1
(en)
|
1997-09-25 |
2002-01-29 |
Gel-Del Technologies, Inc. |
Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
|
ATE219693T1
(de)
|
1998-04-27 |
2002-07-15 |
Surmodics Inc |
Bioaktive wirkstoffe freisetzende beschichtungen
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20030007991A1
(en)
*
|
1998-09-25 |
2003-01-09 |
Masters David B. |
Devices including protein matrix materials and methods of making and using thereof
|
WO2000040089A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Massachusetts Eye And Ear Infirmary |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
CA2360938C
(en)
|
1999-02-02 |
2008-01-08 |
Warren Oliver Haggard |
Controlled release composite
|
US6198966B1
(en)
*
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US6554424B1
(en)
|
1999-03-01 |
2003-04-29 |
Boston Innovative Optices, Inc. |
System and method for increasing the depth of focus of the human eye
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
ES2315598T3
(es)
*
|
1999-10-21 |
2009-04-01 |
Alcon, Inc. |
Dispositivo para la administracion de farmacos.
|
JP2003511204A
(ja)
|
1999-10-21 |
2003-03-25 |
アルコン,インコーポレイティド |
テノン下薬剤送出
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US8162927B2
(en)
*
|
2000-03-21 |
2012-04-24 |
Gholam A. Peyman |
Method and apparatus for accommodating intraocular lens
|
US20070031473A1
(en)
*
|
2005-08-05 |
2007-02-08 |
Peyman Gholam A |
Drug delivery system and method
|
US6478776B1
(en)
|
2000-04-05 |
2002-11-12 |
Biocardia, Inc. |
Implant delivery catheter system and methods for its use
|
US8101200B2
(en)
|
2000-04-13 |
2012-01-24 |
Angiotech Biocoatings, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
AU2001283357A1
(en)
*
|
2000-08-14 |
2002-02-25 |
Pharmacia Corporation |
Drug delivery system with bilayer electrodes
|
US6719750B2
(en)
*
|
2000-08-30 |
2004-04-13 |
The Johns Hopkins University |
Devices for intraocular drug delivery
|
IL155479A0
(en)
|
2000-11-03 |
2003-11-23 |
Control Delivery Sys Inc |
Improved device and method for treating conditions of a joint
|
DE60114229T2
(de)
|
2000-11-29 |
2006-07-06 |
Allergan, Inc., Irvine |
Verhinderung von transplantatabstossung im auge
|
US6756049B2
(en)
*
|
2000-12-29 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
WO2002053128A2
(en)
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
CA2432225C
(en)
*
|
2001-01-03 |
2008-01-15 |
Michael J. Brubaker |
Sustained release drug delivery devices with prefabricated permeable plugs
|
EP1404295B1
(en)
*
|
2001-01-03 |
2007-10-10 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
US6991808B2
(en)
*
|
2001-01-26 |
2006-01-31 |
Bausch & Lomb Inc. |
Process for the production of sustained release drug delivery devices
|
AU2002229434A1
(en)
*
|
2001-01-29 |
2002-08-12 |
Bernard B. Fresco |
Controlled release microsphere system for administration of drug to the eye
|
US6713081B2
(en)
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
IL158527A0
(en)
*
|
2001-04-26 |
2004-05-12 |
Control Delivery Sys Inc |
Sustained release drug delivery system containing codrugs
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
US7563255B2
(en)
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
US7883717B2
(en)
|
2001-06-12 |
2011-02-08 |
Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
ES2271301T3
(es)
*
|
2001-07-23 |
2007-04-16 |
Alcon, Inc. |
Dispositivo de suministro de farmaco oftalmico.
|
PT1409065E
(pt)
|
2001-07-23 |
2007-03-30 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
CA2456025C
(en)
*
|
2001-08-29 |
2011-11-22 |
Ricardo A.P. De Carvalho |
An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
IN2014DN10834A
(pt)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US8685427B2
(en)
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
US7621907B2
(en)
*
|
2002-03-11 |
2009-11-24 |
Alcon, Inc. |
Implantable drug delivery system
|
US8623393B2
(en)
*
|
2002-04-29 |
2014-01-07 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
US6976584B2
(en)
*
|
2002-06-26 |
2005-12-20 |
Bausch & Lomb Incorporated |
Package for surgical implant
|
MXPA05000632A
(es)
*
|
2002-07-15 |
2005-03-31 |
Alcon Inc |
Composiciones para implante farmaceuticas, lipofilas, no polimericas para uso intraocular.
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
US8920826B2
(en)
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
CA2498191C
(en)
*
|
2002-09-18 |
2012-04-10 |
Trustees Of The University Of Pennsylvania |
Method of inhibiting choroidal neovascularization
|
US20050143363A1
(en)
*
|
2002-09-29 |
2005-06-30 |
Innorx, Inc. |
Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
PT1585743E
(pt)
*
|
2002-12-19 |
2007-07-12 |
Pfizer |
Compostos de 2- (1h-indazol-6-ilamin)-benzamida como inibidores de proteína-cinases úteis para o tratamento de doenças aftálmicas.
|
WO2004058272A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20040143327A1
(en)
*
|
2003-01-17 |
2004-07-22 |
Ku David N. |
Solid implant
|
MXPA05007717A
(es)
*
|
2003-01-24 |
2005-09-30 |
Control Delivery Sys Inc |
Liberacion controlada de agentes altamente solubles.
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
ZA200505989B
(en)
*
|
2003-02-20 |
2006-12-27 |
Alcon Inc |
Use the steroids to treat ocular disorders
|
KR20050102653A
(ko)
*
|
2003-02-20 |
2005-10-26 |
알콘, 인코퍼레이티드 |
병적 눈 혈관신생 치료용 글루코코르티코이드 제제
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
CA2524271C
(en)
*
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
US7416546B2
(en)
*
|
2003-05-05 |
2008-08-26 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US8034048B2
(en)
*
|
2003-05-05 |
2011-10-11 |
Boston Scientific Scimed, Inc. |
Tissue patches and related delivery systems and methods
|
US7589107B2
(en)
*
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
KR20060019579A
(ko)
*
|
2003-06-13 |
2006-03-03 |
알콘, 인코퍼레이티드 |
병적 눈 혈관형성을 치료하기 위한 비-스테로이드성항-염증제 제제
|
US8029477B2
(en)
*
|
2003-12-19 |
2011-10-04 |
Ethicon Endo-Surgery, Inc. |
Applier with safety for implantable medical device
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
US8715243B2
(en)
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
MXPA05011517A
(es)
*
|
2003-07-10 |
2005-12-12 |
Alcon Inc |
Dispositivo para el suministro de medicamentos oftalmicos.
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
EP1660013A4
(en)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
|
CA2539324A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
WO2005048873A2
(en)
*
|
2003-11-12 |
2005-06-02 |
Alcon, Inc. |
Kit for administration of a drug
|
MXPA06005431A
(es)
*
|
2003-11-13 |
2007-01-25 |
Psivida Inc |
Dispositivos de suministro de liberacion sostenida inyectables.
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US8162897B2
(en)
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20050137538A1
(en)
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20070053963A1
(en)
*
|
2004-01-13 |
2007-03-08 |
Hotchkiss Robert N |
Drug delivery to a joint
|
US7544176B2
(en)
|
2005-06-21 |
2009-06-09 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation
|
US20050194303A1
(en)
*
|
2004-03-02 |
2005-09-08 |
Sniegowski Jeffry J. |
MEMS flow module with filtration and pressure regulation capabilities
|
US7364564B2
(en)
|
2004-03-02 |
2008-04-29 |
Becton, Dickinson And Company |
Implant having MEMS flow module with movable, flow-controlling baffle
|
US7384550B2
(en)
|
2004-02-24 |
2008-06-10 |
Becton, Dickinson And Company |
Glaucoma implant having MEMS filter module
|
CA2563150A1
(en)
|
2004-04-06 |
2005-10-20 |
Surmodics, Inc. |
Coating compositions for bioactive agents
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
AU2005240078A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
|
WO2006002366A2
(en)
*
|
2004-06-24 |
2006-01-05 |
Surmodics, Inc. |
Biodegradable ocular devices, methods and systems
|
WO2006004795A2
(en)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
US7922702B2
(en)
*
|
2004-07-02 |
2011-04-12 |
Qlt Inc. |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
US20070281007A1
(en)
*
|
2004-08-27 |
2007-12-06 |
Jacob Jules S |
Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
US7402156B2
(en)
*
|
2004-09-01 |
2008-07-22 |
Alcon, Inc. |
Counter pressure device for ophthalmic drug delivery
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
US20060046960A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
US20060116404A1
(en)
|
2004-09-24 |
2006-06-01 |
Gary Robinson |
CAI-based systems and methods for the localized treatment of ocular and other diseases
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
US20060067980A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
WO2006039551A2
(en)
*
|
2004-09-30 |
2006-04-13 |
The Regents Of The University Of California |
Local administration of retinoids to treat deficiencies in dark adaptation
|
US20060067979A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
US20060116682A1
(en)
*
|
2004-11-18 |
2006-06-01 |
Longo Marc N |
Surgical implant and methods of making and using the same
|
JP2008521489A
(ja)
*
|
2004-11-24 |
2008-06-26 |
テラカイン コーポレイション |
眼球内薬物送達のための移植物
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
WO2006068898A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060163111A1
(en)
*
|
2004-12-23 |
2006-07-27 |
Baril Daniel J |
Device holder apparatus
|
CN104147005B
(zh)
|
2005-02-09 |
2018-07-03 |
参天制药株式会社 |
用于治疗疾病或病症的液体制剂
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
JP2008535847A
(ja)
*
|
2005-04-08 |
2008-09-04 |
サーモディクス,インコーポレイティド |
網膜下に送達するための持続放出インプラント
|
WO2006122414A1
(en)
*
|
2005-05-17 |
2006-11-23 |
Matregen Corp. |
Depot for sustained and controlled delivery of methotrexate
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
WO2007002183A2
(en)
*
|
2005-06-21 |
2007-01-04 |
Bausch & Lomb Incorporated |
Drug delivery device for implanting in the eye comprising a drug core and a preformed permeable crystalline polymeric disc
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
US7651483B2
(en)
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
US8067189B2
(en)
*
|
2005-09-01 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV
|
WO2007047626A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
MX2008006076A
(es)
|
2005-11-09 |
2008-12-16 |
Combinatorx Inc |
Metodos, composiciones y kits para el tratamiento de condiciones medicas.
|
US20080293691A1
(en)
|
2005-11-29 |
2008-11-27 |
Smithkline Beecham Corporation |
Treatment Method
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
AU2007212271B2
(en)
|
2006-02-09 |
2012-11-01 |
Santen Pharmaceutical Co., Ltd. |
Stable formulations, and methods of their preparation and use
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
DK2001466T3
(en)
|
2006-03-23 |
2016-02-29 |
Santen Pharmaceutical Co Ltd |
LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
|
JP5208916B2
(ja)
|
2006-03-31 |
2013-06-12 |
キュー エル ティー インク. |
鼻涙系用の薬物送達方法、構造および組成物
|
US7871399B2
(en)
*
|
2006-05-17 |
2011-01-18 |
Alcon Research, Ltd. |
Disposable ophthalmic injection device
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
JP4827626B2
(ja)
*
|
2006-06-14 |
2011-11-30 |
キヤノン株式会社 |
被制御機器、遠隔制御システムおよび遠隔制御システムの制御方法、プログラム
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
WO2008008281A2
(en)
|
2006-07-07 |
2008-01-17 |
Proteus Biomedical, Inc. |
Smart parenteral administration system
|
ATE549022T1
(de)
|
2006-08-07 |
2012-03-15 |
Bausch & Lomb |
Behandlung von infektionen und deren folgeleiden mit kombinierten dissoziierten glocucorticoid- rezeptor-agonisten und antiinfektionswirkstoffen
|
DK2056799T3
(da)
*
|
2006-08-31 |
2013-10-28 |
Bausch & Lomb |
Sammensætninger og fremgangsmåder til behandling eller forebyggelse af glaukom eller progression deraf
|
WO2008027557A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Spherics, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
DK2061444T3
(da)
*
|
2006-09-11 |
2011-06-27 |
Bausch & Lomb |
Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergi
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
KR20090067218A
(ko)
*
|
2006-10-16 |
2009-06-24 |
알콘 리서치, 리미티드 |
일회용 단부를 구비하는 안과용 핸드 피스의 작동 방법
|
CA2664477A1
(en)
*
|
2006-10-16 |
2008-09-04 |
Alcon Research, Ltd. |
Universal rechargeable limited reuse assembly for ophthalmic hand piece
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
EP1973528B1
(en)
*
|
2006-11-17 |
2012-11-07 |
Supernus Pharmaceuticals, Inc. |
Sustained-release formulations of topiramate
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US20080299176A1
(en)
*
|
2007-05-30 |
2008-12-04 |
Yu-Chin Lai |
Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
US8092541B2
(en)
|
2007-08-03 |
2012-01-10 |
Warsaw Orthopedic, Inc. |
Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
US7910123B2
(en)
*
|
2007-09-05 |
2011-03-22 |
Warsaw Orthopedic |
Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent
|
US20090062922A1
(en)
*
|
2007-09-05 |
2009-03-05 |
Mckay William F |
Method and apparatus for delivering treatment to a joint
|
NZ583861A
(en)
|
2007-09-07 |
2012-08-31 |
Quadra Logic Tech Inc |
Lacrimal implants with an angled intersection between its sections so as to bias a portion of the body against the tissue surface
|
CN102670352A
(zh)
*
|
2007-09-07 |
2012-09-19 |
Qlt股份有限公司 |
用于泪腺植入物的插入和抽出工具
|
CA2698580C
(en)
*
|
2007-09-07 |
2016-10-11 |
Qlt Plug Delivery, Inc. |
Lacrimal implant detection
|
RU2478366C2
(ru)
|
2007-09-07 |
2013-04-10 |
Клт Инк. |
Лекарственные ядра для замедленного высвобождения терапевтических средств
|
US20090087443A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
CA3014633C
(en)
|
2007-10-08 |
2022-05-17 |
Aurinia Pharmaceuticals Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
US9125979B2
(en)
|
2007-10-25 |
2015-09-08 |
Proteus Digital Health, Inc. |
Fluid transfer port information system
|
GB0722484D0
(en)
*
|
2007-11-15 |
2007-12-27 |
Ucl Business Plc |
Solid compositions
|
WO2009086483A2
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
EP2257250A2
(en)
|
2008-01-29 |
2010-12-08 |
Gilbert H. Kliman |
Drug delivery devices, kits and methods therefor
|
CN104825270B
(zh)
*
|
2008-02-18 |
2017-10-24 |
马缇医疗股份有限公司 |
泪管植入物及相关方法
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
US8475823B2
(en)
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
US20090269390A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Medtronic, Inc. |
Medical devices, polymers, compositions, and methods for delivering a haloacetate
|
EP2276471B1
(en)
|
2008-04-30 |
2018-08-08 |
Mati Therapeutics Inc. |
Composite lacrimal insert and related methods
|
BRPI0912182A2
(pt)
*
|
2008-05-09 |
2015-10-06 |
Qlt Plug Delivery Inc |
distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
KR20110132369A
(ko)
*
|
2009-02-23 |
2011-12-07 |
큐엘티 인코포레이티드 |
눈물 임플란트 및 관련 방법
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
CN102655823B
(zh)
*
|
2009-05-18 |
2016-04-20 |
多斯医学公司 |
药物洗脱眼植入物
|
ES2921527T3
(es)
*
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Administración de fármaco en segmento anterior
|
US9017725B2
(en)
*
|
2009-06-09 |
2015-04-28 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
IN2012DN00352A
(pt)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
KR20120114368A
(ko)
|
2010-02-01 |
2012-10-16 |
프로테우스 디지털 헬스, 인코포레이티드 |
양 손목을 이용한 데이터 수집 시스템
|
US20110189174A1
(en)
*
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
AU2011210648B2
(en)
|
2010-02-01 |
2014-10-16 |
Otsuka Pharmaceutical Co., Ltd. |
Data gathering system
|
ES2552954T3
(es)
|
2010-04-30 |
2015-12-03 |
Alexion Pharmaceuticals, Inc. |
Anticuerpos anti-C5a y métodos para el uso de los anticuerpos
|
JP2013526572A
(ja)
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
DK2600930T3
(da)
|
2010-08-05 |
2021-03-01 |
Forsight Vision4 Inc |
Injektionsapparat til lægemiddelafgivelse
|
ES2894940T3
(es)
|
2010-08-05 |
2022-02-16 |
Forsight Vision4 Inc |
Aparato para tratar un ojo
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
US9415193B2
(en)
|
2011-03-04 |
2016-08-16 |
W. L. Gore & Associates, Inc. |
Eluting medical devices
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
AU2012271728B2
(en)
|
2011-06-14 |
2016-10-20 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
DK2750660T3
(en)
|
2011-08-29 |
2016-12-12 |
Mati Therapeutics Inc |
FILING WITH PROLONGED RELEASE OF ACTIVE AGENTS to treat glaucoma and ocular hypertension
|
WO2013040238A2
(en)
*
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
EP2755615B1
(en)
*
|
2011-09-14 |
2022-04-06 |
Forsight Vision5, Inc. |
Ocular insert apparatus
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
EP3903733A1
(en)
|
2011-09-16 |
2021-11-03 |
ForSight Vision4, Inc. |
Fluid exchange apparatus
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US9545303B2
(en)
|
2011-12-02 |
2017-01-17 |
Acufocus, Inc. |
Ocular mask having selective spectral transmission
|
AU2012347926B2
(en)
|
2011-12-05 |
2018-03-15 |
Incept, Llc |
Medical organogel processes and compositions
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
MX351261B
(es)
|
2012-06-01 |
2017-10-06 |
Surmodics Inc |
Aparato y método para recubrir catéteres con globo.
|
US9901715B2
(en)
|
2012-09-05 |
2018-02-27 |
W. L. Gore Associates, Inc. |
Retractable sheath devices, systems, and methods
|
US20140100530A1
(en)
|
2012-10-05 |
2014-04-10 |
Miguel A. Linares |
Attachable uterine device with integrated and time release medicinal administering component and insertion tool for implanting such a device
|
AU2013334169B2
(en)
|
2012-10-26 |
2018-03-29 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
CA2940513C
(en)
|
2013-03-11 |
2023-08-15 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for ocular inflammation
|
US9204962B2
(en)
|
2013-03-13 |
2015-12-08 |
Acufocus, Inc. |
In situ adjustable optical mask
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9427922B2
(en)
|
2013-03-14 |
2016-08-30 |
Acufocus, Inc. |
Process for manufacturing an intraocular lens with an embedded mask
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
ES2972168T3
(es)
|
2013-03-28 |
2024-06-11 |
Forsight Vision4 Inc |
Implante oftálmico para administración de sustancias terapéuticas
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
AU2014350095B9
(en)
*
|
2013-11-14 |
2019-09-12 |
Eyed Pharma |
Eye device
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
US20150342875A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
US10258503B2
(en)
|
2014-07-15 |
2019-04-16 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
US10080877B2
(en)
|
2014-07-25 |
2018-09-25 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a drug cartridge
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
BR112017002466A2
(pt)
|
2014-08-08 |
2017-12-05 |
Forsight Vision4 Inc |
formulações estáveis e solúveis de inibidores da tirosina cinase do receptor, e métodos para a sua preparação
|
US9814673B2
(en)
*
|
2014-08-12 |
2017-11-14 |
Imprimis Pharmaceuticals, Inc. |
Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof
|
US10507101B2
(en)
|
2014-10-13 |
2019-12-17 |
W. L. Gore & Associates, Inc. |
Valved conduit
|
RU2708958C2
(ru)
|
2014-11-10 |
2019-12-12 |
Форсайт Вижн4, Инк. |
Расширяемые устройства доставки лекарственных средств и способы использования
|
EP3283004A4
(en)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
US10206978B2
(en)
|
2015-06-08 |
2019-02-19 |
Retinal Solutions Llc |
Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
|
US10669321B2
(en)
|
2015-06-08 |
2020-06-02 |
Retinal Solutions Llc |
Retinal capillary regeneration with synthetic norrin protein
|
US10202429B2
(en)
|
2015-06-08 |
2019-02-12 |
Retinal Solutions Llc |
Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
WO2017176886A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
USD802755S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
US11406533B2
(en)
|
2017-03-17 |
2022-08-09 |
W. L. Gore & Associates, Inc. |
Integrated aqueous shunt for glaucoma treatment
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
US11220544B2
(en)
|
2017-07-14 |
2022-01-11 |
Cytomx Therapeutics, Inc. |
Anti-CD166 antibodies and uses thereof
|
WO2019023617A1
(en)
*
|
2017-07-27 |
2019-01-31 |
University Of Utah Research Foundation |
DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
|
EP4218813A3
(en)
|
2017-07-27 |
2023-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration anti-c5 antibody formulations
|
CA3080187A1
(en)
|
2017-10-26 |
2019-05-02 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus)
|
KR20200093581A
(ko)
|
2017-11-21 |
2020-08-05 |
포사이트 비젼4, 인크. |
확장 가능한 포트 전달 시스템을 위한 유체 교환 기기 및 사용 방법
|
SG11202005947RA
(en)
|
2018-05-24 |
2020-07-29 |
Celanese Eva Performance Polymers Corp |
Implantable device for sustained release of a macromolecular drug compound
|
US11689849B2
(en)
|
2018-05-24 |
2023-06-27 |
Nureva, Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
EP3801378A4
(en)
|
2018-05-24 |
2022-02-23 |
Celanese EVA Performance Polymers LLC |
IMPLANTABLE DEVICE FOR THE DELAYED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
|
EP3843676A1
(en)
|
2018-08-29 |
2021-07-07 |
W.L. Gore & Associates, Inc. |
Drug therapy delivery systems and methods
|
BR112021008063A2
(pt)
|
2018-10-30 |
2021-08-10 |
Alexion Pharmaceuticals, Inc. |
dosagem subcutânea e administração de anticorpos anti-c 5 para tratamento de hemoglobinúria paroxística noturna (pnh)
|
US11628466B2
(en)
|
2018-11-29 |
2023-04-18 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
CA3177829A1
(en)
|
2018-12-12 |
2020-06-18 |
Kite Pharma, Inc. |
Chimeric antigen and t cell receptors and methods of use
|
US11678983B2
(en)
|
2018-12-12 |
2023-06-20 |
W. L. Gore & Associates, Inc. |
Implantable component with socket
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
AU2021259628A1
(en)
|
2020-04-24 |
2023-01-05 |
Millennium Pharmaceuticals, Inc. |
Anti-CD19 antibodies and uses thereof
|
CN112569457B
(zh)
*
|
2020-12-10 |
2024-02-13 |
北京大学第三医院(北京大学第三临床医学院) |
一种持续给药囊管系统
|
WO2022215054A1
(en)
|
2021-04-09 |
2022-10-13 |
Takeda Pharmaceutical Company Limited |
Antibodies targeting complement factor d and uses therof
|
PE20242205A1
(es)
|
2021-04-26 |
2024-11-19 |
Millennium Pharm Inc |
Anticuerpos anti-adgre2 y usos de los mismos
|
EP4330284A2
(en)
|
2021-04-26 |
2024-03-06 |
Millennium Pharmaceuticals, Inc. |
Anti-clec12a antibodies and uses thereof
|
US20240366632A1
(en)
|
2021-08-31 |
2024-11-07 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the treatment of ocular rosacea
|
CA3236038A1
(en)
|
2021-10-20 |
2023-04-27 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|